These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 422697)

  • 41. [Studies on the pathogenesis of arterial hypertension in acromegaly. I. The renin-angiotensin-aldosterone system].
    Słowińska-Srzednicka J; Zgliczyński S; Puciłowska J
    Pol Arch Med Wewn; 1983 Feb; 69(2):129-36. PubMed ID: 6351030
    [No Abstract]   [Full Text] [Related]  

  • 42. [Is the renin-angiotensin system implicated in the hypertensive effect of a water-soluble tissue extract?].
    de Gandarias JM; Casis E; Iribar C; Casis L
    Rev Esp Fisiol; 1988 Jun; 44(2):191-5. PubMed ID: 3194576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
    Hollenberg NK; Williams GH; Burger B; Ishikawa I; Adams DF
    J Clin Invest; 1976 Jan; 57(1):39-46. PubMed ID: 1245602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
    Marks AD; Marks DB; Kanefsky TM; Adlin VE; Channick BJ
    J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Strategy for hormonal study in the arterial hypertension of acromegaly].
    Strauch G
    Ann Med Interne (Paris); 1983; 134(3):242-5. PubMed ID: 6625420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arterial hypertension in acromegaly: altered dopaminergic control of aldosterone secretion.
    Słowińska-Srzednicka J; Puciłowska J; Zgliczyński S
    Clin Exp Hypertens A; 1987; 9(11):1843-58. PubMed ID: 2830067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An investigation into the pathogenesis of hypertension in acromegaly.
    Snow MH; Piercy DA; Robson V; Wilkinson R
    Clin Sci Mol Med; 1977 Jul; 53(1):87-91. PubMed ID: 872524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aldosterone in acromegaly.
    Marks P; Vincent R; Wilson B; Delassale A
    Am J Med Sci; 1984; 287(3):16-9. PubMed ID: 6375368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Arterial hypertension in acromegaly].
    Słowińska-Srzednicka J; Zgliczyński S; Puciłowska J; Jeske W
    Pol Arch Med Wewn; 1987 Aug; 78(2):81-8. PubMed ID: 3271289
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiac function in acromegaly.
    Hirsch EZ; Sloman JG; Martin FI
    Am J Med Sci; 1969 Jan; 257(1):1-8. PubMed ID: 4236707
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on the pathogenesis of arterial hypertension in acromegaly. II. Disorders of prolactin secretion].
    Słowińska-Srzednicka J; Zgliczyński S; Puciłowska J; Jeske W
    Pol Arch Med Wewn; 1983 Feb; 69(2):137-44. PubMed ID: 6889151
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acromegaly and cardiac function].
    Passa P; Masquet C; Gourgon R; Canivet J
    Ann Endocrinol (Paris); 1973; 34(6):647-56. PubMed ID: 4793503
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin II degradation by human Cohn plasma fractions.
    WOLF RL; MENDLOWITZ M; GITLOW SE; ROBOZ J; NAFTCHI N
    Proc Soc Exp Biol Med; 1963 Jan; 112():209-12. PubMed ID: 14001548
    [No Abstract]   [Full Text] [Related]  

  • 54. Pathogenesis and prevalence of hypertension in acromegaly.
    Bondanelli M; Ambrosio MR; degli Uberti EC
    Pituitary; 2001 Sep; 4(4):239-49. PubMed ID: 12501974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system.
    Kraatz C; Benker G; Weber F; Lüdecke D; Hirche H; Reinwein D
    Klin Wochenschr; 1990 Jun; 68(12):583-7. PubMed ID: 2198380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood pressure response to an angiotensin II antagonist in patients with acromegaly.
    Ogihara T; Hata T; Maruyama A; Mikami H; Nakamaru M; Okada Y; Kumahara Y
    J Clin Endocrinol Metab; 1979 Jan; 48(1):159-62. PubMed ID: 422697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly.
    Strauch G; Vallotton MB; Touitou Y; Bricaire H
    N Engl J Med; 1972 Oct; 287(16):795-9. PubMed ID: 4341550
    [No Abstract]   [Full Text] [Related]  

  • 60. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly.
    Moore TJ; Thein-Wai W; Dluhy RG; Dawson-Hughes BF; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1980 Aug; 51(2):215-22. PubMed ID: 6995474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.